Robert Snoeck

Q: What Schools Are Affiliated With Robert Snoeck

Robert Snoeck is affiliated with the following schools: University of California, Berkeley, KU Leuven, Cardiff University, Stanford University, University of Bologna

Robert Snoeck's AcademicInfluence.com Rankings

Robert Snoeck

Engineering

#4940

World Rank

#6166

Historical Rank

Electrical Engineering

#1301

World Rank

#1392

Historical Rank

engineering Degrees

Robert Snoeck

Computer Science

#6295

World Rank

#6639

Historical Rank

Data Science

#117

World Rank

#120

Historical Rank

Computational Linguistics

#1052

World Rank

#1066

Historical Rank

Machine Learning

#1994

World Rank

#2020

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Robert Snoeck's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Why Is Robert Snoeck Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Snoeck's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. (1988) (1518)
Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus (1988) (506)
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine (1993) (329)
Synthesis and antiviral activity of new pyrazole and thiazole derivatives. (2009) (281)
Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine] (1998) (268)
Activities of various compounds against murine and primate polyomaviruses (1997) (236)
HPMPC (cidofovir), PMEA (adefovir) and Related Acyclic Nucleoside Phosphonate Analogues: A Review of their Pharmacology and Clinical Potential in the Treatment of Viral Infections (1997) (234)
Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma (2018) (233)
(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication (1988) (224)
Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain. (2000) (176)
Adjuvant Low‐Dose Cidofovir Therapy for BK Polyomavirus Interstitial Nephritis in Renal Transplant Recipients (2005) (176)
Synthesis and antiviral activity of imidazo[1,2-a]pyridines (1999) (170)
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. (1992) (167)
Synthesis of imidazo[1,2-a]pyridines as antiviral agents. (1998) (165)
Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base. (1999) (164)
A case of human Orf in an immunocompromised patient treated successfully with cidofovir cream (2001) (152)
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). (1994) (149)
Antiadenovirus Activities of Several Classes of Nucleoside and Nucleotide Analogues (2005) (148)
Successful treatment of a squamous papilloma of the hypopharynx‐esophagus by local injections of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine (1995) (147)
Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base. (1999) (146)
Synthesis of acyclo-C-nucleosides in the imidazo[1,2-a]pyridine and pyrimidine series as antiviral agents. (1996) (132)
6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity. (2002) (130)
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. (2001) (127)
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. (2011) (127)
Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds (1991) (122)
Synthesis and antiherpes virus activity of 1,5-anhydrohexitol nucleosides. (1993) (121)
Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agents. (2010) (115)
The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications (2013) (114)
Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses (1994) (110)
Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). (1990) (102)
Synthesis, biological evaluation, and structure analysis of a series of new 1,5-anhydrohexitol nucleosides. (1995) (97)
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III) (2000) (95)
Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. (1995) (95)
Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. (2001) (93)
Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigiata. (1994) (93)
5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity. (2003) (93)
Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. (2000) (91)
Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. (1998) (91)
Antivaccinia Activities of Acyclic Nucleoside Phosphonate Derivatives in Epithelial Cells and Organotypic Cultures (2002) (91)
Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II. (2007) (90)
5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. (1991) (89)
9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. (1991) (89)
Cidofovir Activity against Poxvirus Infections (2010) (88)
Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent design. (1992) (88)
Nosocomial bacteremia caused byBacillus species (1988) (85)
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2. (1996) (85)
Polyomavirus infection in pediatric renal transplant recipients: Evaluation using a quantitative real‐time PCR technique (2004) (84)
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. (1992) (84)
Drug targets in cytomegalovirus infection. (2009) (83)
Antiviral enantiomeric preference for 5'-noraristeromycin. (1994) (81)
Sulphated Polymers are Potent and Selective Inhibitors of Various Enveloped Viruses, Including Herpes Simplex Virus, Cytomegalovirus, Vesicular Stomatitis Virus, Respiratory Syncytial Virus, and Toga-, Arena- and Retroviruses (1990) (78)
Herpes simplex virus drug-resistance: new mutations and insights. (2013) (75)
Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. (2004) (75)
Susceptibilities of Several Clinical Varicella-Zoster Virus (VZV) Isolates and Drug-Resistant VZV Strains to Bicyclic Furano Pyrimidine Nucleosides (2005) (74)
Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus. (2007) (74)
Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice (2006) (72)
Antitumor potential of acyclic nucleoside phosphonates. (1999) (71)
CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. (2002) (71)
Activity of the Anti-Orthopoxvirus Compound ST-246 against Vaccinia, Cowpox and Camelpox Viruses in Cell Monolayers and Organotypic Raft Cultures (2007) (71)
ANTIVIRAL POTENTIAL OF A NEW GENERATION OF ACYCLIC NUCLEOSIDE PHOSPHONATES, THE 6-[2-(PHOSPHONOMETHOXY)ALKOXY]-2,4-DIAMINOPYRIMIDINES (2005) (70)
Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro. (1991) (69)
The cyclohexene ring system as a furanose mimic: synthesis and antiviral activity of both enantiomers of cyclohexenylguanine. (2000) (69)
Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. (1990) (68)
Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. (2005) (67)
New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents. (1992) (65)
Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. (2002) (65)
Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. (2000) (64)
Synthesis and antiviral activity of 3-substituted imidazo[1,2-a]pyridines. (1994) (64)
Meningoradiculoneuritis due to acyclovir‐resistant varicella zoster virus in an acquired immune deficiency syndrome patient (1994) (64)
Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds. (2004) (63)
Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides. (2005) (60)
ACYCLIC/CARBOCYCLIC GUANOSINE ANALOGUES AS ANTI-HERPESVIRUS AGENTS (2001) (60)
Novel inhibitors of human CMV. (2008) (59)
Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues (2008) (57)
Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. (1984) (57)
Antiviral Activity of Triazine Analogues of 1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine (Cidofovir) and Related Compounds (2007) (56)
Synthesis, antiviral and anticancer activity of some novel thioureas derived from N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide. (2009) (55)
Novel Therapeutics for Epstein–Barr Virus (2019) (55)
In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs (2011) (53)
The large tumor antigen: a "Swiss Army knife" protein possessing the functions required for the polyomavirus life cycle. (2013) (53)
Antiviral Activity of low-MW Dextran Sulphate (Derived from dextran MW 1000) Compared to Dextran Sulphate Samples of Higher MW (1991) (52)
A new topical treatment for resistant herpes simplex infections. (1993) (51)
Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogues. (1993) (51)
New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones-thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation. (2002) (51)
Anti-influenza virus activity and structure–activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains (2009) (50)
Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism. (2004) (50)
Cidofovir in the treatment of HPV-associated lesions. (2001) (50)
Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity. (2007) (50)
Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin (2005) (50)
Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation. (2011) (50)
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study. (2009) (49)
The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications (2015) (49)
Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation. (2005) (49)
Broad-Spectrum Antiviral Activity and Mechanism of Antiviral Action of the Fluoroquinolone Derivative K-12 (1998) (48)
Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine. (2004) (48)
Antiviral therapy of herpes simplex. (2000) (48)
Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. (1998) (47)
Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities. (2014) (47)
Activities of Several Classes of Acyclic Nucleoside Phosphonates against Camelpox Virus Replication in Different Cell Culture Models (2007) (47)
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping (2015) (47)
Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus. (2002) (47)
Iron as a potential co‐factor in the pathogenesis of Kaposi's sarcoma? (1998) (47)
Papillomavirus and treatment. (2006) (47)
Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones. (2001) (46)
Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus (1995) (46)
Organotypic Epithelial Raft Cultures as a Model for Evaluating Compounds against Alphaherpesviruses (2005) (45)
5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. (2007) (45)
Inhibiting effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice. (1998) (45)
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication (2014) (44)
Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. (2011) (44)
DNA Polymerase Mutations in Drug-Resistant Herpes Simplex Virus Mutants Determine In Vivo Neurovirulence and Drug-Enzyme Interactions (2007) (44)
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis (2016) (43)
The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication (1994) (43)
Kaposi's sarcoma, oncogenic viruses, and iron. (2001) (42)
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. (2002) (42)
Camelpox virus. (2011) (40)
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. (2002) (40)
Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. (1993) (40)
Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridines. (1991) (40)
Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: Report of a case (1998) (40)
Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy. (2013) (39)
Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives. (2006) (39)
Treatment of herpes simplex virus infections (1999) (39)
Dihydropyrimidinone/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation. (2018) (38)
From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors. (2005) (38)
3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties. (1995) (38)
GS-9191 Is a Novel Topical Prodrug of the Nucleotide Analog 9-(2-Phosphonylmethoxyethyl)Guanine with Antiproliferative Activity and Possible Utility in the Treatment of Human Papillomavirus Lesions (2009) (38)
New neplanocin analogues. 7. Synthesis and antiviral activity of 2-halo derivatives of neplanocin A. (1996) (38)
Activities of Acyclic Nucleoside Phosphonates against Orf Virus in Human and Ovine Cell Monolayers and Organotypic Ovine Raft Cultures (2005) (38)
Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. (1994) (38)
In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA. (2007) (38)
Local treatment of HPV‐induced skin lesions by Cidofovir (2002) (37)
Synthesis and antiviral activities of 8-alkynyl-, 8-alkenyl-, and 8-alkyl-2'-deoxyadenosine analogues. (1994) (37)
Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives. (2007) (37)
Synthesis and antiviral activity of acyclic nucleosides with a 3(S),5-dihydroxypentyl or 4(R)-methoxy-3(S),5-dihydroxypentyl side chain. (1992) (37)
Poly(Hydroxy)Carboxylates as Selective Inhibitors of Cytomegalovirus and Herpes Simplex Virus Replication (1992) (37)
The novel L- and D-amino acid derivatives of hydroxyurea and hydantoins: synthesis, X-ray crystal structure study, and cytostatic and antiviral activity evaluations. (2005) (37)
Preparation of acyclo nucleoside phosphonate analogues based on cross-metathesis (2008) (36)
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia. (2015) (36)
Activities of Alkoxyalkyl Esters of Cidofovir (CDV), Cyclic CDV, and (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine against Orthopoxviruses in Cell Monolayers and in Organotypic Cultures (2006) (36)
Tricyclic analogues of acyclovir and ganciclovir. Influence of substituents in the heterocyclic moiety on the antiviral activity. (1994) (36)
The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations. (2007) (35)
Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs (2008) (35)
Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals (2013) (35)
Sulphated Cyclodextrins are Potent anti-HIV Agents Acting Synergistically with 2′,3′-dideoxynucleoside Analogues (1991) (35)
Furano Pyrimidines as Novel Potent and Selective Anti-VZV Agents (2001) (34)
Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of a terminal halogen substitution in the side-chain. (2000) (34)
Next‐generation treatment strategies for human papillomavirus‐related head and neck squamous cell carcinoma: where do we go? (2012) (34)
Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II. (1993) (34)
Herpes virus infections. (1988) (34)
Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. (1996) (34)
Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles (2000) (33)
4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. (2009) (33)
New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1. (1996) (33)
The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations. (2009) (33)
Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents. (2010) (33)
Disciplinary Approach to Understanding Cytomegalovirus Disease (1993) (33)
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir (2001) (32)
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? (2004) (32)
Advances in the treatment of varicella-zoster virus infections. (2013) (31)
In vivo antiherpesvirus activity of N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine (1995) (31)
Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication. (1998) (31)
Inhibitory Activities of Three Classes of Acyclic Nucleoside Phosphonates against Murine Polyomavirus and Primate Simian Virus 40 Strains (2007) (31)
Emerging drugs for varicella-zoster virus infections (2011) (30)
Design, synthesis, antiviral and cytostatic activity of ω-(1H-1,2,3-triazol-1-yl)(polyhydroxy)alkylphosphonates as acyclic nucleotide analogues (2014) (30)
Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity. (2005) (30)
Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. (2006) (30)
Systemic cidofovir in papillomatosis. (2001) (30)
Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry. (1989) (29)
An epimer of 5'-noraristeromycin and its antiviral properties. (1994) (29)
Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds. (2007) (29)
Advances and Perspectives in the Management of Varicella-Zoster Virus Infections (2021) (29)
Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique. (1991) (29)
Design, Synthesis, and Molecular Docking Studies of a Conjugated Thiadiazole-Thiourea Scaffold as Antituberculosis Agents. (2016) (28)
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine. (2008) (27)
Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. (1996) (27)
Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus. (2016) (26)
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives. (2006) (26)
Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds (1995) (26)
Spectrum of Activity and Mechanisms of Resistance of Various Nucleoside Derivatives against Gammaherpesviruses (2014) (26)
Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection. (2010) (26)
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase (2016) (25)
6‐[2‐Phosphonomethoxy)Alkoxy]‐2,4‐Diaminopyrimidines: A New Class of Acyclic Pyrimidine Nucleoside Phosphonates with Antiviral Activity (2004) (25)
(+-)-carbocyclic 5'-nor-2'-deoxyguanosine and related purine derivatives: synthesis and antiviral properties. (1992) (25)
Viral DNA Polymerase Inhibitors (2009) (25)
Pyridine oxide derivatives: structure-activity relationship for inhibition of human immunodeficiency virus and cytomegalovirus replication in cell culture (2002) (25)
N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase (2013) (25)
Synthesis and antiviral activity of three pyrazole analogues of distamycin A. (1994) (25)
Synthesis and antiviral activity of 5'-deoxypyrazofurin. (1993) (24)
Dual infection with polyomavirus BK and acyclovir‐resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient (2007) (24)
Activity and Mechanism of Action of HDVD, a Novel Pyrimidine Nucleoside Derivative with High Levels of Selectivity and Potency against Gammaherpesviruses (2013) (24)
Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3‐Triazolylbenzyl‐aminophosphonates (2015) (24)
ProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents. (2014) (24)
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma (2015) (24)
Synthesis and biological properties of C-2 triazolylinosine derivatives. (2012) (24)
Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives. (2000) (24)
Inhibition of Vaccinia Virus Replication by Two Small Interfering RNAs Targeting B1R and G7L Genes and Their Synergistic Combination with Cidofovir (2009) (23)
Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus (1991) (23)
Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. (2007) (23)
S-Adenosyl-L-homocysteine Hydrolase Inhibitors as Anti-Viral Agents: 5′-Deoxyaristeromycin (1993) (23)
Specific Targeting of the F13L Protein by St-246 Affects Orthopoxvirus Production Differently (2008) (23)
Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues. (2009) (23)
Synthesis and Antiviral Activity of Acyclic Nucleotide Analogues Derived from 6-(Aminomethyl)purines and Purine-6-carboxamidines (1996) (23)
Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines. (2007) (22)
Current Pharmacological Approaches to the Therapy of Varicella Zoster Virus Infections (1999) (22)
Differential Susceptibility of Several Drug-Resistant Strains of Herpes Simplex Virus Type 2 to Various Antiviral Compounds (1997) (22)
Polysulfonates Derived from Metal Thiolate Complexes as Inhibitors of HIV-1 and Various other Enveloped Viruses In Vitro (2002) (22)
Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides. (1999) (22)
Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides (2013) (22)
Comparative activity of various compounds against clinical strains of herpes simplex virus (1992) (22)
Polyanion inhibitors of human immunodeficiency virus and other viruses. 6. Micelle-like anti-HIV polyanionic compounds based on a carbohydrate core. (1997) (22)
Design, antiviral and cytostatic properties of isoxazolidine-containing amonafide analogues (2015) (22)
Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus. (2008) (22)
Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study (2002) (22)
Successful use of intralesional and intravenous cidofovir in association with indole‐3‐carbinol in an 8‐year‐old girl with pulmonary papillomatosis (2005) (21)
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action. (2008) (21)
Synthesis and biological evaluation of some new 1,3,4-thiadiazole and 1,2,4-triazole derivatives from L-methionine as antituberculosis and antiviral agents (2015) (21)
Novel agents for the therapy of varicella-zoster virus infections (2000) (21)
Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir®) (1996) (21)
Synthesis and antiviral evaluation of 6-(alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one nucleosides and analogues with ethynyl, ethenyl, and ethyl spacers at C6 of the furopyrimidine core. (2007) (21)
Synthesis and Antiviral Evaluation of Phosphoramidate Derivatives of (E)-5-(2-Bromovinyl)-2′-Deoxyuridine (2001) (21)
New prodrugs of Adefovir and Cidofovir (2011) (21)
Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents. (1992) (21)
Antiviral activity of ganciclovir elaidic acid ester against herpesviruses. (2000) (21)
Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDS. (1993) (21)
Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): effect of terminal unsaturation in the side-chain. (2001) (20)
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity (2017) (20)
Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures (2016) (20)
Polyanion inhibitors of human immunodeficiency virus and other viruses. 1. Polymerized anionic surfactants. (1995) (20)
Solvent-Free Synthesis of Pyrimidine Nucleoside-Aminophosphonate Hybrids and Their Biological Activity Evaluation (2010) (20)
Successful treatment of human papillomavirus (HPV) associated giant squamous papilloma of the hypopharynx and esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) (1994) (20)
Activities of Different Classes of Acyclic Nucleoside Phosphonates against BK Virus in Primary Human Renal Cells (2011) (20)
Synthesis and Antiviral Activity of 1,3-Disubstituted Uracils against HIV-1 and HCMV (2003) (20)
Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activity. (2001) (20)
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions (2009) (20)
From β‐Amino‐γ‐sultone to Unusual Bicyclic Pyridine and Pyrazine Heterocyclic Systems: Synthesis and Cytostatic and Antiviral Activities (2011) (19)
Polyanion inhibitors of human immunodeficiency virus and other viruses. 5. Telomerized anionic surfactants derived from amino acids. (1997) (19)
Specific Inhibition of Orthopoxvirus Replication by a Small Interfering RNA Targeting the D5R Gene (2008) (19)
Specific therapies for human papilloma virus infections. (1998) (19)
Antiviral and Cytostatic Evaluation of the Novel 6-acyclic Chain Substituted Thymine Derivatives (2005) (19)
Anti-Varicella—Zoster Virus Bicyclic Nucleosides: Replacement of Furo by Pyrro Base Reduces Antiviral Potency (2000) (19)
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome. (2001) (19)
A Rapid Phenotypic Assay for Detection of Acyclovir-Resistant Varicella-Zoster Virus with Mutations in the Thymidine Kinase Open Reading Frame (2000) (19)
Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies. (2014) (18)
Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage (2013) (18)
No apparent effect of cidofovir in epidermodysplasia verruciformis. (2000) (18)
Synthesis and anti-HCMV activity of 1-[ω-(phenoxy)alkyl]uracil derivatives and analogues thereof (2013) (18)
Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra. (2018) (18)
Evaluation of Novel Acyclic Nucleoside Phosphonates against Human and Animal Gammaherpesviruses Revealed an Altered Metabolism of Cyclic Prodrugs upon Epstein-Barr Virus Reactivation in P3HR-1 Cells (2013) (18)
Successful kinase bypass with new acyclovir phosphoramidate prodrugs. (2008) (18)
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs. (2017) (17)
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives (2019) (17)
Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice. (2003) (17)
Mutations Conferring Resistance to Viral DNA Polymerase Inhibitors in Camelpox Virus Give Different Drug-Susceptibility Profiles in Vaccinia Virus (2012) (17)
Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids. (2004) (17)
Chemotherapy of varicella zoster virus infections. (1994) (17)
Desferrioxamine enhances aids‐associated Kaposi's sarcoma tumor development in a xenograft model (2002) (16)
Iron as a potential cofactor in the pathogenesis of Kaposi's sarcoma (1999) (16)
Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2'-deoxy nucleoside analogues. (2012) (16)
Anti-(herpes simplex virus) activity of 4'-thio-2'-deoxyuridines: a biochemical investigation for viral and cellular target enzymes. (2000) (16)
Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents. (2010) (16)
Imidazothiadiazine dioxides: synthesis and antiviral activity. (1999) (16)
New Polyacetal Polysulphate Active against Human Immunodeficiency Virus and other Enveloped Viruses (1992) (16)
Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptides. (1996) (16)
Alkyne-Azide Click Chemistry Mediated Carbanucleosides Synthesis (2007) (16)
Skin mild hypoxia enhances killing of UVB-damaged keratinocytes through reactive oxygen species-mediated apoptosis requiring Noxa and Bim. (2012) (16)
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. (1991) (16)
Synthesis and evaluation of antiviral , antitubercular and anticancer activities of some novel thioureas derived from 4-aminobenzohydrazide hydrazones (2010) (16)
Carbocyclic 5'-nor "reverse" fleximers. Design, synthesis, and preliminary biological activity. (2011) (15)
SYNTHESIS AND CRYSTAL STRUCTURE OF NA3V(SO4)3. SPECTROSCOPIC CHARACTERIZATION OF NA3V(SO4)3 AND NAV(SO4)2 (1994) (15)
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity (2013) (15)
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice (1993) (15)
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. (2004) (15)
Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues. (2011) (15)
Dipyridamole Potentiates the Activity of Various Acyclic Nucleoside Phosphonates against Varicella-Zoster Virus, Herpes Simplex Virus and Human Cytomegalovirus (1994) (14)
Synthesis and Anti-Varicella-Zoster Virus Activity of Some Novel Bicyclic Nucleoside Inhibitors: Effect of Enhanced Aqueous Solubility (2000) (14)
Synthesis and antiviral evaluation of C5-substituted-(1,3-diyne)-2'-deoxyuridines. (2012) (14)
Synthesis, and cytotoxic activity of N(ind)-alkoxy derivatives of antibiotic arcyriarubin and dechloro-rebeccamycin aglycon. (2002) (14)
Bicyclic nucleoside inhibitors of Varicella-Zoster virus: the effect of branching in the p-alkylphenyl side chain. (2002) (14)
Synthesis and biological evaluation of 1,2-disubstituted carbonucleosides of 6-substituted purine and 8-azapurine. (1999) (14)
[Verrucous carcinoma of the esophagus. A case report]. (2005) (14)
Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis (2021) (14)
Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor (2016) (14)
Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy (2015) (14)
Sequestration of human cytomegalovirus by human renal and mammary epithelial cells. (2014) (14)
Synthesis and biological evaluation of 5-(alkyn-1-yl)-1-(p-toluenesulfonyl)uracil derivatives (2006) (14)
Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity (2018) (14)
Structure—Antiviral Activity Relationship in the Series of Pyrimidine and Purine N-[2-(2-Phosphonomethoxy)ethyl] Nucleotide Analogues. Part 1. Derivatives Substituted at the Carbon Atoms of the Base. (1999) (13)
Crystal Structure of (S)-1-Phenylethylammonium (R)-Mandelate and a Comparison of Diastereomeric Mandelate Salts of 1-Phenylethylamine. (1994) (13)
Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs (2020) (13)
New neplanocin analogues. VIII. Synthesis and biological activity of 6'-C-ethyl, -ethenyl, and -ethynyl derivatives of neplanocin A. (1997) (13)
Synthesis of 2'-aminomethyl derivatives of N-(2-(phosphonomethoxy)ethyl) nucleotide analogues as potential antiviral agents. (1996) (13)
Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors (2010) (13)
Synthesis and biological evaluation of acyclic nucleotide analogues with a furo(2,3-d)pyrimidin- 2(3H)-one base (2010) (13)
Influence of 4′-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2 (2020) (13)
Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity. (2004) (13)
Synthesis and antiviral activity of 6-chloropurine arabinoside and its 2'-deoxy-2'-fluoro derivative. (1996) (12)
Tricyclic etheno analogs of PMEG and PMEDAP: synthesis and biological activity. (2006) (12)
Novel halogenated 3-deazapurine, 7-deazapurine and alkylated 9-deazapurine derivatives of l-ascorbic or imino-l-ascorbic acid: Synthesis, antitumour and antiviral activity evaluations (2015) (12)
Synthetic Sulfur Carotenoids. III: Carotenoid Thiones -- First Preparation and Spectroscopic Properties. (1994) (12)
Synthesis and Anti‐herpetic Activity of Phosphoramidate ProTides (2013) (12)
KAY-2-41, a Novel Nucleoside Analogue Inhibitor of Orthopoxviruses In Vitro and In Vivo (2013) (12)
Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents (2010) (12)
New Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity (2016) (12)
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization (2021) (12)
Antiherpesvirus Activities of Two Novel 4′-Thiothymidine Derivatives, KAY-2-41 and KAH-39-149, Are Dependent on Viral and Cellular Thymidine Kinases (2014) (12)
Study of Camelpox Virus Pathogenesis in Athymic Nude Mice (2011) (12)
3-Benzamido, ureido and thioureidoimidazo[1,2-a]pyridine derivatives as potential antiviral agents. (2001) (12)
Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4'-phosphono-but-2'-en-1'-yl]purine nucleosides. (2012) (12)
Antiviral activity spectrum of phenoxazine nucleoside derivatives (2019) (12)
Mechanism of the Antiviral Activity of New Aurintricarboxylic Acid Analogues (1996) (11)
Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides (2018) (11)
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms (2016) (11)
Phosphonoamidate prodrugs of C5‐substituted pyrimidine acyclic nucleosides for antiviral therapy (2017) (11)
N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity. (2014) (11)
Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model. (1991) (11)
Novel carbocyclic nucleosides containing a cyclobutyl ring. Guanosine and adenosine analogues. (1998) (11)
Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety (2012) (11)
Synthesis of Imidazo[1,2-a]pyridine Derivatives as Antiviral Agents (2001) (11)
Synthesis and Antiviral Activity of 2 and 3-Substituted Imidazo[1,2-a]pyrimidine (1995) (11)
Antiviral potential of “new” acyclic nucleoside phosphonates, the 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines (2004) (11)
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice. (2013) (11)
New treatments for genital herpes. (2002) (11)
Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates (2016) (11)
Antiviral Drug-Resistance Typing Reveals Compartmentalization and Dynamics of Acyclovir-Resistant Herpes Simplex Virus Type-2 (HSV-2) in a Case of Neonatal Herpes. (2014) (11)
BICYCLIC NUCLEOSIDE INHIBITORS OF VARICELLA-ZOSTER VIRUS (VZV): EFFECT OF TERMINAL UNSATURATION IN THE SIDE-CHAIN (2001) (11)
Synthesis and biological evaluation of bicyclic furano pyrimidine nucleosides as inhibitors of human cytomegalovirus (2003) (10)
Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates (2018) (10)
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients. (1986) (10)
Synthesis and Antiviral and Cytostatic Activities of Carbocyclic Nucleosides Incorporating a Modified Cyclobutane Ring (1999) (10)
Amidate Prodrugs of Cyclic 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]adenine with Potent Anti-Herpesvirus Activity. (2018) (10)
Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir (2013) (10)
Treatment of progressive multifocal leukoencephalopathy (PLM) with Cidofovir in an AIDS patient (1996) (10)
Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products. (2017) (10)
Design, synthesis and preliminary antiviral screening of new N-phenylpyrazole and dihydroisoxazole derivatives (2010) (10)
Ovine Skin Organotypic Cultures Applied to the Ex vivo Study of Orf Virus Infection (2005) (10)
Methyl-2-arylidene hydrazinecarbodithioates: synthesis and biological activity (2013) (10)
Novel Isoxazolidine and γ-Lactam Analogues of Homonucleosides (2019) (10)
Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment. (1998) (9)
Synthesis and Antiviral Activities of Some Novel Carbocyclic Nucleosides (1996) (9)
CRISPR/Cas9 Editing of the Polyomavirus Tumor Antigens Inhibits Merkel Cell Carcinoma Growth In Vitro (2019) (9)
The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase (2018) (9)
SYNTHESIS AND ANTI-HIV ACTIVITY OF THYMIDINE ANALOGUES BEARING A 4′-CYANOVINYL GROUP AND SOME DERIVATIVES THEREOF (2001) (9)
Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation (2021) (9)
Sonication-Assisted Synthesis of (E)-2-Methyl-but-2-enyl Nucleoside Phosphonate Prodrugs (2016) (9)
Synthesis and Antiviral Activity of 6-Benzoyl-Benzoxazolin-2-One and 6-Benzoyl-Benzothiazolin-2-One Derivatives (1999) (9)
Design, synthesis and biological evaluation of 2′-deoxy-2′,2′-difluoro-5-halouridine phosphoramidate ProTides (2011) (9)
Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses (2021) (9)
In vitro Sensitivity of Kaposi's Sarcoma Cells to Various Chemotherapeutic Agents Including Acyclic Nucleoside Phosphonates (1999) (9)
SYNTHESIS OF AMINO ACIDS WITH MODIFIED PRINCIPAL PROPERTIES. III: SULFUR-CONTAINING AMINO ACIDS (1994) (9)
Phosphonylated Acyclic Guanosine Analogues with the 1,2,3-Triazole Linker (2015) (8)
(D)- AND (L)-CYCLOHEXENYL-G, A NEW CLASS OF ANTIVIRAL AGENTS: SYNTHESIS, CONFORMATIONAL ANALYSIS, MOLECULAR MODELING, AND BIOLOGICAL ACTIVITY (2001) (8)
BICYCLIC FURO PYRIMIDINE NUCLEOSIDES WITH ARYLOXYPHENYL AND HALOPHENYL SUBSTITUTED SIDE CHAINS AS POTENT AND SELECTIVE VARICELLA-ZOSTER VIRUS INHIBITORS (2001) (8)
An Epimer of 5′-Noraristeromycin and Its Antiviral Properties. (1994) (8)
Metabolic and Pharmacological Characteristics of the Bicyclic Nucleoside Analogues (BCNAs) as Highly Selective Inhibitors of Varicella-Zoster Virus (VZV) (2003) (8)
Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis (2017) (8)
Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV). (1990) (8)
57FE MOSSBAUER SPECTROSCOPIC STUDIES OF THE FERROCENE MOLECULAR REORIENTATION IN AIPO4-5 AND AIPO4-8 FRAMEWORKS (1994) (8)
Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: Efficient synthesis and antiviral activity (2011) (8)
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro (1990) (8)
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro (1996) (8)
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Synthesis and Biological Evaluation of 2′,3′-Dideoxy- 3′-fluoro and 2′-Deoxy-xylo Derivatives (2003) (8)
Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV). (2007) (8)
Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus. (2009) (8)
Antiviral Activity of 3-(3,5-Dimethylbenzyl)Uracil Derivatives Against Hiv-1 and HCMV (2007) (8)
2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743. (2009) (8)
Novel bicyclic furanopyrimidines with dual anti-VZV and -HCMV activity. (2003) (8)
Phenotypic Resistance of Herpes Simplex Virus Type 1 Strains Selected in Vitro with Antiviral Compounds and Combinations Thereof (1996) (8)
Synthesis and Antiviral Evaluation of Some 3′‐Fluoro Bicyclic Nucleoside Analogues (2004) (8)
(±)-7-deazaaristeromycin lacking the hydroxymethyl substituent (1993) (7)
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus (VZV): Pd-Catalysed Synthesis of 5-aryl Derivatives and Their Biological Evaluation (2001) (7)
Evaluating phenotype and genotype of drug-resistant strains in herpesviruses (2001) (7)
Formulation of acyclovir (core)-dexpanthenol (sheath) nanofibrous patches for the treatment of herpes labialis. (2021) (7)
Human cytomegalovirus (HCMV) strains selected under selective pressure of phosphonoformate (PFA) are resistant for both PFA and phosphonylmethoxyethyl (PME) derivatives in vitro (1995) (7)
Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature (2018) (7)
Preparation of Some Acetylated Deoxy-pento- and -hexofuranoses and their Deacetylation. (1994) (7)
Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides. (2017) (7)
Perturbation of cytokine production by bone marrow stromal cells after cytomegalovirus infection (1993) (7)
Monitoring drug resistance for herpesviruses. (2000) (7)
A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing. (2017) (7)
Isoxazolidine Conjugates of N3-Substituted 6-Bromoquinazolinones—Synthesis, Anti-Varizella-Zoster Virus, and Anti-Cytomegalovirus Activity (2018) (7)
Evaluation of Novel Phosphoramidate ProTides of the 2′-Fluoro Derivatives of a Potent Anti-Varicella Zoster Virus Bicyclic Nucleoside Analogue (2010) (7)
Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV). (2017) (7)
E-5-(2-Chlorovinyl)-2′-Deoxycytidine: Synthesis and Antiherpetic Activity (1990) (7)
Acyclic nucleoside and nucleotide analogues derived from 1-deaza and 3-deazaadenine (1990) (7)
Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides (2016) (7)
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus Modified on the Sugar Moiety: 3′ and 5′ Derivatives (2004) (7)
Design, Synthesis, and the Biological Evaluation of a New Series of Acyclic 1,2,3‐Triazole Nucleosides (2017) (7)
Pyridine-Type Complexes of Transition-Metal Halides. VIII. Preparation, Characterization and Single-Crystal Structure of Difluorotetrakis(3,5-dimethylpyridine)cobalt(II).n Hydrate [n ~= 2.6(3)]. (1994) (6)
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: 5′-Chloro and 3′-Chloro Derivatives (2003) (6)
New treatments for genital herpes (2002) (6)
Copper(II) Complexes of 2-Amino-2-hydroxymethyl-1,3-propanediol. Part 5. Synthesis, Structure and Thermal Behavior of cis-[2-Amino-2-hydroxymethyl-1,3-propanediol-O,O,N][2-amino-2-hydroxymethyl-1,3-propanediolato-O,N]aquacopper(II) Halide Monohydrate [Cu(C4H10NO3)(C4H11NO3)(H2O)]X.H2O, where X = F-, (1994) (6)
Emimycin and its nucleoside derivatives: Synthesis and antiviral activity. (2018) (6)
Use of polymerase chain reaction for diagnosis of disseminated adenovirus infection. (2002) (6)
Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity (2020) (6)
Human Brain Tumour Cell Lines as Cell Substrate to Demonstrate Sensitivity/Resistance of Herpes Simplex Virus Types 1 and 2 to Nucleoside Analogues (1994) (6)
Toward the discovery of dual HCMV–VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides (2015) (6)
Novel Non-Nucleoside Human Cytomegalovirus Inhibitors Based Upon Tsao Nucleoside Derivatives: Structure-Activity Relationships (2007) (6)
Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro (1992) (6)
Synthesis, Anti-varicella-zoster virus and Anti-cytomegalovirus Activity of 4,5-Disubstituted 1,2,3-(1H)-Triazoles. (2019) (6)
Therapy of poxvirus infections (2007) (6)
Synthesis and Biological Activity of Some 2-Aminopurine Carbonucleosides (1997) (6)
Mutations in adenosine deaminase-like (ADAL) protein confer resistance to the antiproliferative agents N6-cyclopropyl-PMEDAP and GS-9219. (2013) (6)
Amidate Prodrugs of O-2-Alkylated Pyrimidine Acyclic Nucleosides Display Potent Anti-Herpesvirus Activity. (2020) (6)
Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss. (2019) (6)
Synthesis of 4′-substituted 2′-deoxy-4′-thiocytidines and its evaluation for antineoplastic and antiviral activities (2019) (6)
Poxviruses Bearing DNA Polymerase Mutations Show Complex Patterns of Cross-Resistance (2022) (6)
Synthesis of uracil–coumarin conjugates as potential inhibitors of virus replication (2019) (5)
Synthesis of 2′‐Aminomethyl Derivatives of N‐(2‐(Phosphonomethoxy) ethyl) Nucleotide Analogues as Potential Antiviral Agents. (1996) (5)
Synthesis and antiviral activity of acyclic nucleoside and nucleotide derivatives of 8-azaadenine (1993) (5)
SYNTHESIS AND IN VITRO EVALUATION OF NOVEL ANTI-VARICELLA-ZOSTER VIRUS (VZV) NUCLEOSIDES (2001) (5)
Therapy of oropharyngeal candidiasis in cancer patients with fluconazole (1987) (5)
Nucleosides and Nucleotides. Part 148. New Neplanocin Analogues. Part 6. Synthesis and Potent Antiviral Activity of 6′-Homoneplanocin A. (1996) (5)
Antiviral and Cytostatic Evaluation of 5‐(1‐Halo‐2‐sulfonylvinyl)‐ and 5‐(2‐Furyl)uracil Nucleosides (2017) (5)
Tenofovir Activating Kinases May Impact the Outcome of HIV Treatment and Prevention (2015) (5)
Therapy for herpesvirus infections (1991) (5)
Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues (2020) (5)
Antiviral activity of 2-phosphonomethoxyalkyl derivatives of N6-substituted 6-aminopurines (1995) (5)
Transplantation and Clinical Immunology XXIII (1991) (5)
NOVEL ARYL SUBSTITUTED BICYCLIC FURO NUCLEOSIDES AS EXTREMELY POTENT AND SELECTIVE ANTI-VZV AGENTS (2001) (5)
Bicyclic Nucleoside Inhibitors of Varicella‐Zoster Virus (VZV): The Effect of a Terminal Halogen Substitution in the Side‐Chain. (2000) (5)
Novel isoxazolidine analogues of homonucleosides and homonucleotides (2016) (5)
Synthesis and Evaluations of “1,4‐Triazolyl Combretacoumarins” and Desmethoxy Analogs (2019) (5)
Comparison of exoEasy Maxi kit (Qiagen) with size-exclusion chromatography qEV columns (Izon Science) for isolation of extracellular vesicles from human plasma (2016) (5)
9-[ ( 2 RS )-3-Fluoro-2-phosphonylmethoxypropyl ] derivatives of purines : A class of highly selective antiretroviral agents in vitro and in vivo (5)
BKTyper: Free Online Tool for Polyoma BK Virus VP1 and NCCR Typing (2020) (5)
Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1 (2016) (5)
Halophenyl Furanopyrimidines as Potent and Selective Anti-VZV Agents (2003) (5)
Synthesis and Antiviral Activities of 3-Aralkyl-Thiomethylimidazo[1,2-b]Pyridazine Derivatives (2003) (5)
Palladium-catalyzed synthesis of (E)-5-(2-acylvinyl)-2′-deoxyuridines and their antiviral and cytotoxic activities (1995) (5)
6-[2-(Phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: A New Class of Acyclic Pyrimidine Nucleoside Phosphonates with Antiviral Activity (2005) (5)
Neopterin: an useful biochemical marker in the monitoring of allogeneic bone marrow transplantation. (1988) (5)
Synthesis and anti-herpes activity of 5-trifluorovinyl-2'-deoxyuridine (1992) (4)
Exploring the purine core of 3′-C-ethynyladenosine (EAdo) in search of novel nucleoside therapeutics (2016) (4)
Design, synthesis and antiviral evaluation of novel acyclic phosphonate nucleotide analogs with triazolo[4,5-b]pyridine, imidazo[4,5-b]pyridine and imidazo[4,5-b]pyridin-2(3H)-one systems (2020) (4)
Herpesvirus infections in immunocompromised patients. (1995) (4)
Synthesis of O[2]- and N[3]-(2-phosphonomethoxy)ethyl derivatives of 6-phenyl- and 6-pyridinyl-5-azacytosine (2011) (4)
Correction: Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products. (2017) (4)
Strategies for the treatment of cytomegalovirus infections (1993) (4)
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis (2021) (4)
Studies of Phase Equilibria in the System MgO--Mo--O in the Temperature Range 1100--1400 K. (1994) (4)
New acetamide derivatives containing (ω-p-bromophenoxyalkyl)uracil moiety and their anticytomegalovirus activity (2020) (4)
Synthesis and antiviral evaluation of cyclopentyl nucleoside phosphonates. (2018) (4)
Thienothiadiazine 2,2-Dioxide Acyclonucleosides: Synthesis and Antiviral Activity (2000) (4)
Combination of azidothymidine (AZT) and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) inhibits the replication of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) and varicella zoster virus (VZV) strains that are deficient in the expression of the viral thymidine kinase (TK) (1995) (4)
Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo. (2002) (4)
THE JOURNEY TOWARDS ELUCIDATING THE ANTI-HCMV ACTIVITY OF ALKYLATED BICYCLIC FURANO PYRIMIDINES (2005) (4)
Synthesis of Acyclo‐C‐nucleosides in the Imidazo(1,2‐a)pyridine and ‐ pyrimidine Series as Antiviral Agents. (1996) (4)
Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient. (2016) (4)
Synthesis and antiviral properties of carbocyclic 3'-oxa-2',3'-dideoxyguanosine and its 7-deazaguanosine analogue. (1993) (4)
Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase. (2020) (4)
Novel Carbocyclic Nucleosides Containing a Cyclopentyl Ring. Adenosine and Uridine Analogues (1997) (4)
[Current acquisitions in antiviral drugs (anti-HIV)]. (1992) (4)
Chemistry of Niobium Chlorides in the CsCl--NaCl Eutectic Melt. 1. Electromotive Force Measurements of NbCl3 in the CsCl--NaCl Eutectic Melt at Temperatures between 600 and 700 degrees C. (1994) (3)
Synthesis of Unusual Bicyclic Nucleosides Bearing an Unsaturated Side-Chain, as Potential Inhibitors of Varicella-Zoster Virus (VZV) (2003) (3)
Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus (2018) (3)
Synthesis of [11C]Cyanoalkylphosphoranes and their Use in the Preparation of 11C-Olefins. (1994) (3)
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. (2018) (3)
Preparation of O-Hydroxyethyl and O-Hydroxypropyl Derivatives of D-Glucose and 2-Acetamido-2-deoxy-D-glucose for Studies of Modified Hyaluronic Acid. (1994) (3)
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Effect of Terminal Aryl Substitution in the Side-Chain (2002) (3)
HYDROXYLATED PCB DERIVATIVES. SYNTHESIS AND STRUCTURE ELUCIDATION BY NMR SPECTROSCOPY AND X-RAY DIFFRACTION (1994) (3)
Synthesis of fluorinated acyclic nucleoside phosphonates with 5-azacytosine base moiety (2019) (3)
Phosphonylated 8-Azahypoxantines as Acyclic Nucleotide Analogs (2015) (3)
Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties (2020) (3)
Fungal surveillance cultures in neutropenic patients receiving prophylactically ketoconazole, amphotericin B or a placebo (1983) (3)
2-(2,4-Dioxy-1,2,3,4-Tetrahydropyrimidin-1-yl)-N-(4-Phenoxyphenyl)-Acetamides as a Novel Class of Cytomegalovirus Replication Inhibitors (2015) (3)
Investigation of tumor-tumor interactions in a double human cervical carcinoma xenograft model in nude mice (2018) (3)
Acyclovir Resistance in Herpes Simplex Viruses: Prevalence and Therapeutic Alternatives. (2022) (3)
Cidofovir: Induction of apoptosis in human papilloma virus (HPV)-containing cell lines (1997) (3)
SAR of alkyloxyphenyl furano pyrimidines: Potent and selective anti-VZV agents (2006) (3)
[Orf nodules and immunosuppression: a case report and review of therapeutics]. (2015) (3)
Synthesis of 3',4'-difluoro-3'-deoxyribonucleosides and its evaluation of the biological activities: discovery of a novel type of anti-HCV agent 3',4'-difluorocordycepin. (2014) (3)
Lymphocyte‐independent pathways underlie the pathogenesis of murine cytomegalovirus‐associated secondary haemophagocytic lymphohistiocytosis (2018) (3)
Synthesis and anti-HCMV Activity of 1-Acyl-β-lactams and 1-Acylazetidines Derived from Phenylalanine. (2004) (3)
In vivo antiviral activity of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine and its cyclic form (2007) (3)
Synthesis and Antiviral Activity of 5′-Deoxypyrazofurin. (1994) (3)
Oral Treatment of Oropharyngeal Candidiasis with Nystatin Versus Ketoconazole in Cancer Patients (1990) (3)
Synthesis and Antiviral Properties of 1-Substituted 3-[ω-(4-Oxoquinazolin-4(3H)-yl)alkyl]uracil Derivatives (2020) (2)
New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity (2022) (2)
Acyclic nucleoside phosphonates containing the amide bond (2016) (2)
Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives (2019) (2)
SYNTHESIS AND BIOLOGICAL EVALUATION OF N- AND O-ALKYLATED BICYCLIC FURANOPYRIMIDINES AS NON-NUCLEOSIDIC INHIBITORS OF HUMAN CYTOMEGALOVIRUS (2005) (2)
New insight in the pathogenesis and treatment of CMV (1996) (2)
Design, synthesis and biological evaluation of novel acyclovir protides (2008) (2)
Antiviral drug susceptibility of herpes simplex type 1 (HSV-1) strains emerging under the selective pressure of (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)cytosine (HPMPC) in vitro (1995) (2)
Synthesis and Antiviral Activity of 5-Heteroaryl-Substituted 2′- Deoxyuridines. (1991) (2)
Synthesis, antiviral, cytotoxic and cytostatic evaluation of N1-(phosphonoalkyl)uracil derivatives (2016) (2)
Practical and Efficient Synthesis of Pyrano[3,2‐c]pyridone, Pyrano[4,3‐b]pyran and Their Hybrids with Nucleoside as Potential Antiviral and Antileishmanial Agents. (2010) (2)
Oral prophylaxis with netilmicin in neutropenic cancer patients (1988) (2)
Antiviral Potency of ST-246 on the Production of Enveloped Orthopoxviruses and Characterization of ST-246 Resistant Vaccinia, Cowpox and Camelpox Viruses (2008) (2)
Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: The Effect of Branching in the p-Alkylphenyl Side Chain. (2006) (2)
Extension of furopyrimidine nucleosides with 5-alkynyl substituent: Synthesis, high fluorescence, and antiviral effect in the absence of free ribose hydroxyl groups (2020) (2)
Carbocyclic Oxetanocins Lacking the C-3′ Methylene. (2010) (2)
Organotypic Epithelial Raft Cultures as a Three-Dimensional In Vitro Model of Merkel Cell Carcinoma (2022) (2)
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2 (2022) (2)
Dual anti-HSV and anti-HIV activity of the lantibiotic Labyrinthopeptin A1 (2014) (2)
Non-Nucleoside Structures Retain Full Anti-HCMV Potency of the Dideoxy Furanopyrimidine Family (2004) (2)
Selection and characterization of (S)-1-[3-hydroxy-2-(phosphonomethoxypropyl)-2,6-diaminopurine [HPMPDAP] resistant camelpox viruses (2009) (2)
Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs) (2002) (2)
Efficacy of PMEG [9-(2-phosphonylmethoxyethyl)-guanine] and its prodrug cPr-PMEDAP [9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine in organotypic cultures of normal and papillomavirus ((HPV)-positive keratinocytes (2004) (2)
Novel N-Substituted 3-Aryl-4-(diethoxyphosphoryl)azetidin-2-ones as Antibiotic Enhancers and Antiviral Agents in Search for a Successful Treatment of Complex Infections (2021) (2)
[Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer]. (1989) (2)
Synthesis and Antiviral Activity of Acyclic Nucleotide Analogues Derived from 6‐(Aminomethyl)purines and Purine‐6‐carboxamidines. (1997) (2)
Synthesis of 5,5-difluoro-5-phosphono-pent-2-en-1-yl nucleosides as potential antiviral agents (2017) (2)
Cross-Metathesis Mediated Synthesis of New Acyclic Nucleoside Phosphonates (2007) (2)
Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs (2018) (2)
Methods in Anti-HCMV Research. (2000) (2)
Squamous papilloma of the oesophagus and human papilloma virus (1994) (1)
Synthesis and Antiviral Evaluation of 3-(2,3-Dihydroxypropyl)furo[2,3-d]pyrimidin-2(3H)-ones (2010) (1)
Synthesis and antiviral activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil against HIV-1. (2004) (1)
Activity of novel acyclic pyrimidine nucleoside phosphonates against poxviruses (2004) (1)
Treatment of severe laryngeal papillomatosis with intralesional injections of Cidofovir R [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC, Vistide R], (1997) (1)
Characterization of cowpox virus (CPV) mutants arising under pressure with different acyclic nucleoside phosphonates (2009) (1)
Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir (2013) (1)
Synthesis and Cytotoxic Activity of Nind-Alkoxy Derivatives of Antibiotic Arcyriarubin and Dechloro-rebeccamycin Aglycon. (2003) (1)
Selective Inhibitors of Nuclear Export (SINE) Compounds Suppress Both HIV Replication and AIDS Related Lymphoma (2015) (1)
Inhibiting effects of PMEG [9-(2-phosphonylmethoxyethyl)guanine] on the growth of human cervical carcinoma xenografts in athymic nude mice (2005) (1)
Conservation of antiviral activity and improved selectivity in PMEO-DAPym upon pyrimidine to triazine scaffold hopping. (2015) (1)
Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives (2019) (1)
Putting drug resistant epithelial herpes keratitis in the spotlight: A case series (2022) (1)
Antiviral Activities of New Cidofovir Analogs Against Camelpox Virus, Used as a Model of Variola Virus, in Human Skin Equivalent Cultures (2007) (1)
6-[2-(Phosphonomethoxy)alkoxy]pyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity (2003) (1)
(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): successful treatment of a patient with disseminated esophageal and hypopharyngeal papillomatosis (1994) (1)
Identification of the type of cells responsible for transfer of herpes simplex virus (HSV) and vaccinia virus (VACV) infection to epithelial cells grown in 3D (2009) (1)
The Twenty-Second International Conference on Antiviral Research (2009) (1)
Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus. (2022) (1)
Antiviral Activity of 3‐(3,5‐Dimethylbenzyl)uracil Derivatives Against HIV‐1 and HCMV (2008) (1)
Bicyclic Furo Pyrimidine Nucleosides with Aryloxyphenyl and Halophenyl Substituted Side Chains as Potent and Selective Varicella—Zoster Virus Inhibitors (2001) (1)
Synthesis of O2‐ and N3‐(2‐Phosphonomethoxy)ethyl Derivatives of 6‐Phenyl‐ and 6‐Pyridinyl‐5‐azacytosine. (2011) (1)
Bicyclic anti-VZV nucleosides: Thieno analogues bearing alkylphenyl side chain result in a reduction in antiviral activity (2004) (1)
Specific phosphorylation of 2-amino-7-[(1,3-dihydroxy-2-propoxymethyl)purine (S2242) in human cytomegalovirus-infected human embryonic lung fibroblasts (1995) (1)
New antiviral agent, 1-( S )-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: esters and base-modified derivatives (2008) (1)
Antiviral effect of the nucleoside analogue cidofovir in the context of sexual transmission of a gammaherpesvirus in mice (2018) (1)
Management of Genital Herpes Defining the Role of Valaciclovir (2004) (1)
Reduced pathogenicity of phenotypically and genotypically characterized cidofovir (CDV)-resistant vaccinia virus (VV) (2005) (1)
5‐(5‐Bromothien‐2‐yl)‐2′‐deoxyuridine and 5‐(5‐Chlorothien‐2‐yl)‐2′‐ deoxyuridine are Equipotent to E‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine in the Inhibition of Herpes Simplex Virus Type I Replication. (1991) (1)
Metabolic and Pharmacological Characteristics of the Bicyclic Nucleoside Analogues (BCNAs) as Highly Selective Inhibitors of Varicella—Zoster Virus (VZV) (2004) (1)
Anti‐HCMV Compounds (2011) (1)
Utilization of 1,3-Dioxolanes in the Synthesis of α-branched Alkyl and Aryl 9-[2-(Phosphonomethoxy)Ethyl]Purines and Study of the Influence of α-branched Substitution for Potential Biological Activity (2018) (1)
Lignosulfonic acid exhibits broad-spectrum anti-HIV and anti-HSV activity and has potential for microbicidal applications (2014) (1)
Is the large T antigen a target for the inhibition of SV40 replication (2010) (1)
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents (2022) (1)
Adjuvant low dose cidofovir therapy and reduction of immunosuppression for BK polyomavirus interstitial nephritis (BKVIN) in renal recipients (2005) (1)
Influence of the 2-Substituent on the Activity of Imidazo[1,2-a]pyridine Derivatives Against Human Cytomegalovirus. (2002) (1)
Labyrinthopeptin A1, a novel lantibiotic peptide, is a dual HIV and HSV entry inhibitor (2013) (1)
Pre-clinical development of the BCNAs: The most potent anti-VZV agents reported to date (2006) (1)
Synthesis and antiviral activity of various N4-acyl derivatives of cidofovir and its 5-azacytosine counterpart, 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine (2008) (1)
Sonication-Assisted Synthesis of (E)-2-Methyl-but-2-enyl Nucleoside Phosphonate Prodrugs. (2016) (1)
Identification of Bicyclic Sulfone Inhibitors of HHV-6 Targeting the HHV-6 U77 Helicase (2011) (1)
M1009 Eradication of Intra-Anal Condylomata Acuminata and Histologically Dysplasia with Combined Intralaesional Cidofovir and Coagulations (2008) (1)
New therapeutic weapons against poxvirus (2008) (1)
Synthesis and Biological Evaluation of Acyclic Nucleotide Analogues of Bicyclic Pyrimidine Bases (2009) (1)
An efficient synthesis and antiviral activity evaluation of 1-[4-(5-phenyl-4, 5 dihydro-1H-pyrazole [& (4, 5 dihydroisoxazole)]-3-yl)-phenyl]-pyrrole-2, 5-dione derivates (2014) (1)
Synthesis and Antiviral Evaluation of Some 3′-Fluoro Bicyclic Nucleoside Analogues. (2004) (1)
Phosphoramidate prodrugs of the most potent and selective anti-VZV bicyclic pyrimidine nucleosides (2005) (1)
Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: 5′-Chloro and 3′-Chloro Derivatives (2004) (1)
Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase. (2022) (1)
N-[2-Hydroxyethoxy)methyl] derivatives of bicyclic furano and pyrrolo pyrimidines and their antiviral evaluation (2004) (1)
Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: Synthesis and Biological Evaluation of 2′,3′‐Dideoxy‐3′‐fluoro and 2′‐Deoxy‐xylo Derivatives (2004) (1)
Bicyclic anti‐VZV Nucleosides: Thieno Analogues Bearing an Alkylphenyl Side Chain Have Reduced Antiviral Activity. (2004) (1)
Preliminary results on the activity of cidofovir for the treatment of cervical intraepithelial neoplasia (CIN) grade III (1997) (1)
New bicyclic nucleoside analogues (BCNAs) show selective and specific activity against human cytomegalovirus (HCMV) (2003) (1)
Abstract of the Meeting of the Belgian Society of Heamotology (December 13 1986) (1987) (0)
New non-nucleoside inhibitors of cytomegalovirus (2007) (0)
Microdilution technique for testing yeast sensitivity and serum antifungal activity after antifungal agent administration (1983) (0)
Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient (2016) (0)
Perspectives for the treatment of human papillomavirus infections (1995) (0)
Design, synthesis and evaluation of novel Anti-VZV BCNAs (2008) (0)
Differing SARs and MOAs emerge for the highly potent anti-VZV, BCNAs, and their anti-HCMV dd analogues (2004) (0)
Towards the optimization of azetidine-containing dipeptides as human cytomegalovirus inhibitors (2008) (0)
di fl uoro-5-phosphono-pent-2-en-1-yl nucleosides as potential antiviral agents † (2017) (0)
Potent and selective activity of new acyclic nucleoside analogues against cytomegalovirus (1987) (0)
Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. Part 2. (1996) (0)
Pharmacokinetics of vorozole in breast cancer patients (pts) (1994) (0)
[Using antiviral drugs for Orthopoxvirus infections]. (2004) (0)
[Present-day tendencies of traumatology in Vienna]. (1952) (0)
Genotypic characterization of various herpes simplex virus type 1 (HSV-1) clones resistant to acyclic nucleoside phosphonates (1997) (0)
Highlights on the mode of action of ST-246, an anti-orthopoxviral compound (2008) (0)
Characterization of drug-resistant herpes simplex virus type 1 (HSV-1) mutants obtained under single-round selection with high-dose brivudin (BVDU) (2002) (0)
Synthesis of Unusual Bicyclic Nucleosides Bearing an Unsaturated Side-Chain, as Potential Inhibitors of Varicella—Zoster Virus (VZV) (2004) (0)
Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships and mechanism of action (2008) (0)
As antivirals appropriate azacytosinderivate (2006) (0)
Some modifications to the bicyclic pyrimidines: a novel class of anti-viral nucleosides (2006) (0)
Twenty-Fourth International Conference on Antiviral Research - Front Pages (2011) (0)
Intracellular metabolism of the novel anti-herpesvirus agent 2-amino-7-[1,3-dihydroxy-2-propoxy)methyl]purine compound S2242 in non-infected and herpesvirus-infected cells (1995) (0)
Synthesis and in vitro Evaluation of Novel anti‐Varicella‐Zoster Virus (VZV) Nucleosides (2001) (0)
[Novel therapeutic weapons against poxviruses]. (2008) (0)
Section Review: Biologicals & Immunologicals: New insights into the pathogenesis and treatment of cytomegalovirus (1996) (0)
Antiviral activity of a novel compound P-4018 against different strains of herpes simplex virus in vitro and in vivo (1997) (0)
Novel Carbocyclic Nucleosides Containing a Cyclopentyl Ring. Adenosine and Uridine Analogues. (1998) (0)
Synthesis and antiviral activity of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine and its ester prodrugs (2007) (0)
Nucleosides and Nucleotides. Part 149. New Neplanocin Analogues. Part 7. Synthesis and Antiviral Activity of 2-Halo Derivatives of Neplanocin A. (1997) (0)
Antiviral activity of D- and L-enantiomers of cyclohexenyl guanine (2000) (0)
Characterization of varicella-zoster virus (VZV) mutants resistant to bicyclic pyrimidine nucleoside analogues (BCNAs) (2003) (0)
Drug susceptibility profiles of recombinant vaccinia virus harboring mutation(s) conferring resistance to cidofovir (2006) (0)
Synthesis and Antiviral Activity of Acyclic Nucleosides with a 3(S),5- Dihydroxypentyl or 4(R)-Methoxy-3(S),5-dihydroxypentyl Side Chain. (1993) (0)
Synthesis and anti‐HIV‐1 and anti‐HCMV Activity of 1‐Substituted 3‐(3,5‐Dimethylbenzyl)uracil Derivatives. (2006) (0)
Chemical stability and intracellular metabolism of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine (2007) (0)
Design and synthesis of novel anti-HCMV agents: Modifications to the bicyclic pyrimidine base (2007) (0)
Antiviral activity of HPMPC (cidofovir) against orf virus in experimentally infected lamb [(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine; Emilia-Romagna] (2004) (0)
(S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC), a potent and selective inhibitor of cytomegalovirus infection in vitro and in vivo (1991) (0)
(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): A new approach for the treatment of human papillomavirus (HPV-induced tumors (1995) (0)
[Surgical treatment of fractures of the femur neck]. (1957) (0)
Structure-activity relationship of a novel class of Aglycoristocetin derivatives with potent and broad activity against influenza viruses (2009) (0)
β-lactam analogs of oxetanocins – synthesis and biological activity (2022) (0)
Successful treatment of severe relapsing anogenital papillomavirus infections in AIDS patients with (S)-1-(3-Hydroxy-2-phosphonyl methoxypropyl) cytosine (HPMPC) (1995) (0)
Activity of 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines against polyomaviruses (2006) (0)
Antiviral activity of the non-nucleoside analogue CMV423 in lymphoblast cells infected with human herpesvirus 6 (2000) (0)
Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-Naphthalenylmethyl Uracil Derivatives and Their Analogues as Probable Inhibitors of Human Cytomegalovirus Replication (2022) (0)
Acyclic/Carbocyclic Guanosine Analogues as Anti‐Herpesvirus Agents (2001) (0)
HPMPC: A new antiviral agent with activity against human papillomavirus (1994) (0)
Polyomavirus BK Genome Comparison Shows High Genetic Diversity in Kidney Transplant Recipients Three Months after Transplantation (2022) (0)
Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral eva (2011) (0)
Activity of 7,8-dihydro-isoquinoline-6-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-amide hydrochloride salt against human cytomegalovirus (HCMV) (2002) (0)
Erratum to “Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs” [Antiv. Res. 73 (2007) 169–174] (2008) (0)
Synthesis and Antiviral Activities of Some Novel Carbocyclic Nucleosides. (1996) (0)
Combination of azidothymidine (AZT) with (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) leads to inhibition of the in vitro replication of herpes simplex virus type 1 (HSV-1), type 2 (HSV-2) and varicella-zoster virus (VZV) strains that are deficient in thymidine kinase (TK) activity (1995) (0)
[Prevention using pefloxacin of infections in cancer patients with granulocytopenia]. (1989) (0)
Pharmacological properties of the novel anti-varicella-zoster virus bicyclic nucleoside analogues (BCNAs) (2002) (0)
Synthesis, Cytostatic and Antiviral Evaluations of the New C-5 Substituted Pyrimidine and Furo[2, 3-d]pyrimidine 4, 5-Didehydro-L-ascorbic Acid Derivatives (2008) (0)
Infection of different human tumor cell lines by human cytomegalovirus (1991) (0)
Restriction endonuclease patterns of HSV-1 and HSV-2 DNA isolated from 2 patients with relapsing episodes (1992) (0)
Synthesis and anti‐HIV Activity of Thymidine Analogues Bearing a 4′‐Cyanovinyl Group and Some Derivatives Thereof. (2002) (0)
Novel Bicyclic Furanopyrimidines with Dual anti‐VZV and ‐HCMV Activity. (2004) (0)
PHASE 1-2 STUDY OF CIDOFOVIR GIVEN INTRALESIONALY IN CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 OR 3 (2003) (0)
Novel mutations in the herpes simplex virus type 1 (HSV-1) DNA polymerase associated with resistance to foscarnet (PFA) and 2-phosphonylmethoxyethyl (PME) derivatives of adenine (PMEA) and 2,6-diaminopurine (PMEDAP) (2002) (0)
Synthesis of acyclic nucleotide analogues derived from 6-(aminomethyl)purines and purine-6-carboxamidines (1996) (0)
Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma (2018) (0)
Adrenal responsiveness during ketoconazole treatment (1984) (0)
Synthesis and Antiviral Activity of Imidazo[1,2-a]pyridines. (1999) (0)
Anti-varicella-zoster virus bicyclic nucleosides: Synthesis and in vitro evaluation of 2 ',3 '-dideoxy nucleoside derivatives (2002) (0)
Successful treatment of severe anogenital papillomavirus infections in AIDS patients with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (1995) (0)
Synthesis and Antiviral Evaluation of C5-Substituted-(1,3-diyne)-2′-deoxyuridines. (2012) (0)
Synthesis and biological evaluation of novel mononuclear Ru(II) compounds as potential antiviral and cytotoxic agents (2016) (0)
Study of the role of the complex formed by the Varicella Zoster virus ORF9p and the cellular Adaptin Protein-1 in the secondary egress (2017) (0)
Inhibition of cytomegalovirus replication by acyclic nucleoside phosphonate analogues: structure-activity relationship (1991) (0)
Novel Aryl Substituted Bicyclic Furo Nucleosides as Extremely Potent and Selective Anti‐VZV Agents (2001) (0)
Synthesis, characterization and biological evaluation of 1,3-thiazolidine-4-ones derived from (2S)-2-benzoylamino-3-methylbutanohydrazide hydrazones (2021) (0)
Antiviral activity of different anti-herpesvirus compounds on keratinocyte organotypic cultures infected with herpes simplex virus and varicella-zoster virus (2000) (0)
Mode of action of CDV treatment of a primary human papillomavirus positive tumor on a secondary, untreated tumor in mice (2017) (0)
CellsVirus Reactivation in P3HR-1 Metabolism of Cyclic Prodrugs upon Gammaherpesviruses Revealed an Altered Phosphonates against Human and Animal Evaluation of Novel Acyclic Nucleoside (2014) (0)
Skin hypoxia enhances killing of UVB-damaged keratinocytes through ROS-mediated apoptosis requiring Noxa and Bim (2011) (0)
Synthesis and Biological Activity of Some 2-Aminopurine Carbonucleosides. (1998) (0)
Specific inhibition of Orthopoxvirus replication by small interfering RNA: involvement in the mechanism of action of ST-246 (2007) (0)
Tripartate Prodrugs of Hydroxy-containing Compounds (2011) (0)
Susceptibility of Human Cytomegalovirus (HCMV) Drug-resistant Viruses to a New Class of Acyclic Nucleoside Phosphonate Analogues (ANPs) (2008) (0)
Squamous papilloma of the oesophagus: diagnosis and treatment (1996) (0)
Although the bicyclic nucleoside analogues (BCNAs) are highly active against varicella-zoster virus (VZV), they are inactive against simian varicella virus (SVV) despite efficient phosphorylation of the BCNAs by SVV-encoded thymidine kinase (2004) (0)
Synthesis and Antiviral Activity of Carbocyclic Oxetanocin Analogues ( C‐OXT‐A, C‐OXT‐G) and Related Compounds. Part 2. (1994) (0)
From the Clinics to the Bench and back to the Clinics: design of a medical treatment for Cervical Intraepithelial Neoplasia (CIN) (2011) (0)
New amphiphilic prodrugs of adefovir and cidofovir (2011) (0)
SURVEY AND SUMMARY Distribution and effects of amino acid changes in drug-resistant (cid:2) and (cid:3) herpesviruses DNA polymerase (2016) (0)
Abstracts of the meeting of the Belgian Society of Internal Medicine (25 April 1987) (1987) (0)
Characterization of the DNA polymerase genes of varicella-zoster virus (VZV) resistant to foscarnet (PFA) and the 2-phosphonomethoxyethyl (PME) derivatives of adenine (Adefovir, PMEA) and 2,6-diaminopurine (PMEDAP) (2004) (0)
ProTides of N-(3-(5-(2 '-deoxyuridine))prop-2-ynyl)octanamide phosphate, a potent and selective inhibitor of thymidylate synthase X from Mycobacterium tuberculosis, as potential anti-tubercular and anti-viral agents (2014) (0)
Treatment of primary tumor with cidofovir reduces tumor growth of primary and untreated secondary HPV positive tumor (2015) (0)
Anti-tumor effect of cidofovir against human papillomavirus positive and negative cells is not exclusively due to DNA damage (2015) (0)
Chem. Pharm. Bull. 54(3) 325—333 (2006) (2006) (0)
Keratinocyte organotypic cultures as a model for studying viral infections (2000) (0)
SAR of monosubstituted phenyl furano pyrimidine as potent and selective anti Varicella-Zoster Virus (VZV) compounds (2006) (0)
Design and synthesis of novel non-nucleoside anti-HCMV agents [Abstract] (2008) (0)
Prospective study of BKV viral load, subclinical histology and exposure to tacrolimus and mycophenolic acid in renal allograft recipients (2006) (0)
Interaction of the bicyclic nucleoside analogues (BCNAs) with human varicella-zoster virus (VZV) and simian varicella virus (SVV) thymidine kinase and VZV DNA polymerase (2003) (0)
Synthesis and Antiviral Activities of 8-Alkynyl-, 8-Alkenyl-, and 8- Alkyl-2′-deoxyadenosine Analogues. (1994) (0)
[Surgical treatment of femur neck fractures]. (1956) (0)
Introduction to the Special Issue dedicated to Prof. Erik De Clercq for reaching the Professor Emeritus status at the Katholieke Universiteit Leuven (2006) (0)
Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage (2013) (0)
Mode of action of cidofovir against human papillomavirus positive and negative cells is not exclusively due to DNA damage (2014) (0)
HPMPC treatment of a patient with esophageal and hypopharyngeal papillomatosis (1994) (0)
The Twentieth International Conference on Antiviral Research (2007) (0)
Enhanced antiviral activity of hexadecyloxypropyl-PME-N-6-cyclopropyl-diaminopurine against herpesviruses, hepatitis B virus and vaccinia virus, in vitro (2007) (0)
Design, Synthesis, Anti-Varicella-Zoster and Antimicrobial Activity of (Isoxazolidin-3-yl)Phosphonate Conjugates of N1-Functionalised Quinazoline-2,4-Diones (2022) (0)
Design, synthesis, and biological evaluation of novel anti-VZV agents (2007) (0)
Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis (2017) (0)
Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinoma (2022) (0)
Polyoma virus in pediatric solid organ transplant recipients evaluation using PCR techniques (2003) (0)
Addition of an adjuvant to cidofovir treatment of primary human papillomavirus positive tumor influences untreated secondary tumor in mice (2016) (0)
Mononuclear cells as a transfer vehicle for orthopoxvirus infection of epithelial cells grown in 3D (2010) (0)
Abstracts of the meeting of the Belgian Society of Medecine (19 October 1985) (1986) (0)
Synthesis and antiviral evaluation of 9-(RS)-[2-phosphonylmethoxy-3-(2-propoxy)propyl]adenine (1991) (0)
Derivatives of 3'‐Azidothymidine with 6‐Cyanopyridone as Base or as Phosphoramidate Ester and their Antiretroviral Activity (2022) (0)
ChemInform Abstract: Uracil Derivatives and Analogues. Part 21. Palladium-Catalyzed Synthesis of (E)-5-(2-Acylvinyl)-2′-deoxyuridines and Their Antiviral and Cytotoxic Activities. (1995) (0)
Synthesis and Antiviral Activity of 6‐Chloropurine Arabinoside and Its 2′‐Deoxy‐2′‐fluoro Derivative. (1997) (0)
CMV423, a potent and selective inhibitor of human herpesvirus 6 exerts its antiviral action through inhibition of cellular protein tyrosine kinase activity (2003) (0)
Isolation of vaccinia virus (VV) mutants resistant to different acyclic nucleoside phosphonate analogues (ANPs) (2004) (0)
Mononuclear cells as a transfer vehicle for herpes simplex virus (HSV) or vaccinia virus (VV) infection of epithelial cells grown in 3D (2007) (0)
Synthesis and antiviral properties of biomimetic iminosugar-based nucleosides. (2022) (0)
A new family of non-nucleoside inhibitors of human cytomegalovirus (HCMV) and varicella-zoster virus (VZV) based on the beta-keto-gamma-sultone template (2005) (0)
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis (2021) (0)
Development of a Model for the Study of Antivirals Against Molluscum Contagiosum Virus (MCV) (2008) (0)
Activity of hydroxyurea (HU) in combination with several antiviral nucleosides against in vitro replication of herpes simplex type 1 (HSV-1) and type 2 (HSV-2) and varicella-zoster virus (VZV) (1995) (0)
Effect of cidofovir on the tumor growth of SiHa (human cervical carcinoma) cells in nude mice (1997) (0)
KAH-39-149, Are Dependent on Viral and -Thiothymidine Derivatives, KAY-2-41 and ' Antiherpesvirus Activities of Two Novel 4 (2014) (0)
Inhibition of HCMV replication by the tetrahydroindolizine CMV423 (1999) (0)
Infections under immunosuppressive therapy: viral, protozoal and fungal pathogens (1989) (0)
Activity of D- and L-enantiomers of cyclohexenyl guanine against herpesviruses (2000) (0)
Fatal course following reduced-intensity HSCT in a patient with cartilage hair hypoplasia and progressive multifocal leukoencephalopathy (2009) (0)
Potent and selective anti-retrovirus activity of 9-(RS)-(3-fluoro-2-phosphonylmethoxypropyl) purine derivatives (1991) (0)
Synthesis and Antiviral Evaluation of N9-[2-(Phosphonomethoxy)ethyl] (PME) Analogues Derived from 8-Substituted Purines (2011) (0)
[Perspectives for the treatment and prevention of herpes simplex infections]. (2002) (0)
(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir®, HPMPC) is a potent inhibitor of murine polyomavirus replication both in vitro and in vivo (1995) (0)
Novel bicyclic fluorescent nucleosides as potent and selective inhibitors of VZV (2000) (0)
2′-Fluorosugar Analogues of the Highly Potent anti-Varicella-Zoster Virus Bicyclic Nucleoside Analogue (BCNA) Cf 1743. (2010) (0)
Synthesis and Antiviral Activity of 3‐Substituted Imidazo(1,2‐a) pyridines. (1995) (0)
Production of human monoclonal antibodies (MoAb) against cytomegalovirus (CMV) antigen (1986) (0)
Highly potent and selective inhibitors of varicella zoster virus based on p-alkyloxyphenyl bicyclic furo pyrimidines (2002) (0)
[Highly specific inhibitors of human immunodeficiency virus type I that are particularly targeted at the reverse transcriptase]. (1993) (0)
Bicyclic furo pyrimidine nucleosides with haloaryl side chains (2003) (0)
Organotypic epithelial raft cultures as a model for evaluation of antivirals against varicella-zoster virus (VZV) (2006) (0)
(D)‐ and (L)‐Cyclohexenyl‐G, a New Class of Antiviral Agents: Synthesis, Conformational Analysis, Molecular Modeling, and Biological Activity (2001) (0)
Solvent-Free Synthesis of Pyrimidine Nucleoside-Aminophosphonate Hybrids and Their Biological Activity Evaluation. (2011) (0)
An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness (2021) (0)
Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses (1992) (0)
Synthesis and biological evaluation of a new series of 5-alkylaryl nucleoside analogues showing anti-HCMV activity (2003) (0)
Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N4-hydroxycytidine (NHC) and a 3′-fluoro-substituted analogue of NHC (2023) (0)
Synthesis and antiviral evaluation of N9-[2-(phosphonomethoxy)ethyl] (PME) analogues derived from 8-substituted purine (2011) (0)
Activity of alkoxyalkyl and alkyl esters of (S)-3-hydroxy-2-phosphonylmethoxypropyl derivatives of cytosine (HPMPC, cidofovir) and adenine (HPMPA) and cyclic cidofovir against orthopoxviruses in vitro and in organotypic epithelial raft cultures (2005) (0)
Antiviral activity of acyclic nucleoside phosphonates with branched 2-(2-phosphonoethoxy)ethyl chain (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert Snoeck?

Robert Snoeck is affiliated with the following schools:

Robert Snoeck's Academic­Influence.com Rankings

Robert Snoeck's Degrees

Similar Degrees You Can Earn

Why Is Robert Snoeck Influential?

Robert Snoeck's Published Works

Published Works

What Schools Are Affiliated With Robert Snoeck?

Robert Snoeck's AcademicInfluence.com Rankings